Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
Clinical trial NCT05753618 · RECRUITING
Trial details
- NCT number
- NCT05753618
- Sponsor
- Ottawa Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2026-10-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.